CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
17 hedge funds and large institutions have $683K invested in Cyclo Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$400K |
| 2 |
XT
2
XTX Topco
George Town,
Cayman Islands
|
$18.3K |
| 3 |
VF
3
Virtu Financial
New York
|
$15K |
| 4 |
4
State Street
Boston,
Massachusetts
|
$45.7K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$341 |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$0 |
| 2 |
2
Osaic Holdings
Scottsdale,
Arizona
|
$852 |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$20.1K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$9.61K |
